EDGAR Filing Documents for 0001683168-23-008734

Form S-1 - General form for registration of securities under the Securities Act of 1933:

SEC Accession No. 0001683168-23-008734

Filing Date

2023-12-08

Accepted

2023-12-08 17:28:07

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	cnspharma_s1.htm iXBRL	S-1	361536
2	FORM OF PLACEMENT AGENT AGREEMENT	cnspharma_ex0101.htm	EX-1.1	57886
3	FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT	cnspharma_ex0410.htm	EX-4.10	103639
4	FORM OF COMMON STOCK PURCHASE WARRANT	cnspharma_ex0411.htm	EX-4.11	107725
5	OPINION	cnspharma_ex0501.htm	EX-5.1	15195
6	SECURITIES PURCHASE AGREEMENT	cnspharma_ex1022.htm	EX-10.22	273925
7	CONSENT	cnspharma_ex2301.htm	EX-23.1	3195
8	CALCULATION OF FILING FEE TABLE	cnspharma_ex107.htm	EX-FILING FEES	30770
12	GRAPHIC	image_001.jpg	GRAPHIC	6360
	Complete submission text file	0001683168-23-008734.txt		1324820

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	cnsp-20231208.xsd	EX-101.SCH	3018
10	XBRL LABEL FILE	cnsp-20231208_lab.xml	EX-101.LAB	34767
11	XBRL PRESENTATION FILE	cnsp-20231208_pre.xml	EX-101.PRE	22719
14	EXTRACTED XBRL INSTANCE DOCUMENT	cnspharma_s1_htm.xml	XML	2838

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027

Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185

CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)